COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,367 Articles (22,803 medRxiv, 8,564 bioRxiv)

Most recent first Previous |  Page 5: Articles 41-50  | Next

Genetic Evidence Indicates the Evolutionary Importance of the SARS-CoV-2 ORF9b protein
Hisner, R., Martin, D. P.
10.64898/2026.02.23.707522 — Posted: 2026-02-24
Reclaiming health: a qualitative, explorative study of long covid recovery journeys involving mind-body approaches.
Deurman, C., Brinkman, V., Slagboom, M., Bussemaker, J., Vos, H. M. M.
10.64898/2026.02.21.26345052 — Posted: 2026-02-23
Genomic Evolution of SARS-CoV-2 Delta Variants Pre- and Post-Omicron Emergence using Alignment-free Machine Learning models
Sankar, S., Anandharaman, K., Selvam, P., Jayaraman, A., Jayakumar, D., Sivadoss, R., Esaki Muthu, S., Velu, V., Larsson, M., Balakrishnan, P.
10.64898/2026.02.20.706927 — Posted: 2026-02-23
PFOA induced metabolic and immune perturbations in a SARS-2 infection model
Lanier, D. N., Rowe Haas, D., Uchimiya, M., Jones, C., Johnson, S., Sakamoto, K., Chappel, J. R., Fry, A. N., Leach, F. E., DeWitt, J., Woodlief, T., Gaul, D. A., Baker, E. S., Fernandez, F. M., Tompkins, S. M., Edison, A. S.
10.64898/2026.02.21.707085 — Posted: 2026-02-23
Randomized incentives to increase participation in COVID testing in rural Kenya
Chieng, B., Crider, Y., Aitken, C., Araka, S. B., Kihoro, R. W., Kanyi, H., Powers, J. E., Tan, B., Paulos, A. P., Gomes, A. S., Nekesa, C., Nekesa, C., Bwire, B., Allela, D. O., Kiiru, J. N., Kremer, M., Njenga, S., Pickering, A.
10.64898/2026.02.15.26346122 — Posted: 2026-02-22
Occupational and Environmental Challenges and Effects of COVID-19 Testing Implementation Experienced by HIV Viral Load Laboratory Staff within a Public Health Sector Laboratory in South Africa
Sarang, S., Matingo-Mutava, E., Cassim, N.
10.64898/2026.02.16.26346134 — Posted: 2026-02-22
Low Dose Naltrexone Prescribing Practices for Children and Adolescents with Long COVID
Villatoro, C., Yonts, A. B., Barter, T., Mohandas, S., Malone, L. A.
10.64898/2026.02.20.26346719 — Posted: 2026-02-22
Assessing the impact of the COVID-19 pandemic on routine childhood vaccination uptake in the Netherlands
Pijpers, J., Haverkate, M., van Gaalen, R., Hahne, S., de Melker, H., van den Hof, S.
10.64898/2026.02.19.26346601 — Posted: 2026-02-20
TMPRSS2 reduces antibody recognition of SARS-CoV-2 spike
Cottignies-Calamarte, A., De Cruz, A., Planchais, C., Porrot, F., Krzypow, M., Jungbauer-Groznica, M., Thuillier, E., Wileveau, A., Staropoli, I., Guivel-Benhassine, F., Rosenbaum, P., Fernandez, I., Rey, F. A., Buchrieser, J., Trouillet-Assant, S., Mouquet, H., Schwartz, O., Bruel, T.
10.64898/2026.02.17.706397 — Posted: 2026-02-20
Potential public health and economic impact of the next-generation COVID-19 vaccine mRNA-1283 in the Netherlands
van der Pol, S., Beck, E., Westra, T., Postma, M., Boersma, C.
10.64898/2026.02.18.26346561 — Posted: 2026-02-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).